Literature DB >> 34113

Abnormal amino acid metabolism and brain protein synthesis during neural development.

J V Hughes, T C Johnson.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 34113     DOI： 10.1007/bf00966321

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


× No keyword cloud information.
  85 in total

1.  THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.

Authors:  J DANCIS; J HUTZLER; M LEVITZ
Journal:  Pediatrics       Date:  1963-08       Impact factor: 7.124

2.  Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia.

Authors:  H W WALLACE; K MOLDAVE; A MEISTER
Journal:  Proc Soc Exp Biol Med       Date:  1957-04

3.  Effects of l-phenylalanine and sodium phenylpyruvate on the formation of adrenaline from l-tyrosine in adrenal medulla in vitro.

Authors:  J B Boylen; J H Quastel
Journal:  Biochem J       Date:  1961-09       Impact factor: 3.857

4.  The mechanism of polyribosome disaggregation in brain tissue by phenylalanine.

Authors:  F Taub; T C Johnson
Journal:  Biochem J       Date:  1975-10       Impact factor: 3.857

5.  Experimentally induced and natural recovery from the effects of phenylalanine on brain protein synthesis.

Authors:  J V Hughes; T C Johnson
Journal:  Biochim Biophys Acta       Date:  1978-02-16

6.  Isozymes of phenylalanine hydroxylase.

Authors:  J A Barranger; P J Geiger; A Huzino; S P Bessman
Journal:  Science       Date:  1972-02-25       Impact factor: 47.728

7.  Glutamine in the phenylketonuric central nervous system.

Authors:  C M McKean; N A Peterson
Journal:  N Engl J Med       Date:  1970-12-17       Impact factor: 91.245

8.  Hyperphenylalanemia: effect on brain polyribosomes can be partially reversed by other amino acids.

Authors:  J V Hughes; T C Johnson
Journal:  Science       Date:  1977-01-28       Impact factor: 47.728

9.  Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics.

Authors:  D J Edwards; K Blau
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

10.  Inhibition of protein synthesis in Krebs 2 ascites cells and cell-free systems by phenylalanine and its effect on leucine and lysine in the amino acid pool.

Authors:  J P Roscoe; M D Eaton; G C Choy
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857
View more
  7 in total

1.  In vitro localization of the protein synthesis defect associated with experimental phenylketonuria.

Authors:  M A Elsliger; G R Thériault; D Gauthier
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

2.  Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.

Authors:  J Pietz; R Kreis; A Rupp; E Mayatepek; D Rating; C Boesch; H J Bremer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Inhibition of cerebral protein kinase activity and cyclic AMP-dependent ribosomal-protein phosphorylation in experimental hyperphenylalaninaemia.

Authors:  S Roberts; B S Morelos
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

4.  Cerebral ribosomal protein phosphorylation in experimental hyperphenylalaninaemia.

Authors:  S Roberts; B S Morelos
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

5.  Use of alpha-methylphenylalanine for studies of brain development in experimental phenylketonuria.

Authors:  G Huether; V Neuhoff
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

6.  Phenylketonuria: clinical and experimental considerations revealed by the use of animal models.

Authors:  J D Lane; V Neuhoff
Journal:  Naturwissenschaften       Date:  1980-05

7.  Effect of experimental hyperphenylalaninemia induced by dietary phenylalanine plus alpha-methylphenylalanine administration on amino acid concentration in neonatal chick brain, plasma, and liver.

Authors:  M Castillo; M F Zafra; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.